Stroke Trial, Recruiting NCT07405762 Sponsor: Xijing Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07405762
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 85 years
  • People who have had an acute stroke caused by a blockage in a major blood vessel at the front of the brain, confirmed by a specialised scan (CTA or MRA)
  • People who have undergone a procedure to remove the blood clot (called endovascular thrombectomy) with a successful result, as measured by a standard medical score after the procedure
  • People whose treatment began within 24 hours of their stroke symptoms starting
  • People who have given written consent to participate, or whose legally authorised representative has done so on their behalf

Who may not be able to join:

  • People who had significant physical disability before their stroke, as measured by a standard disability scale (confirm with trial site)
  • People who have severely reduced consciousness within 24 hours after the clot removal procedure, as measured by a standard consciousness scale (confirm with trial site)
  • People whose skull structure makes it impossible to obtain clear brain blood flow readings using a specialised ultrasound technique called Transcranial Doppler
  • People with conditions that may interfere with brain activity monitoring (EEG), such as a history of serious brain injury, a gap or defect in the skull, or metal devices inside the skull
  • People with conditions affecting the nerves or muscles in a way that would interfere with certain nerve conduction tests used in this trial, such as nerve damage in the limbs, neck nerve problems, or muscle disease
  • People with serious failure of major organs, active cancer, or a life expectancy of less than 3 months
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lang Jin, Xijing Hospital

Phone: +86-29-84773664

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xijing Hospital
Registry
ClinicalTrials.gov
Start date
5 February 2026
Est. completion
5 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Trajectory of Neurovascular Decoupling Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov